Having found that many of the genes inhibited by THZ1 are regulated in an EGF-dependent manner, we hypothesized that inhibition of CDK7-mediated transcription via THZ1 could potentiate the effects of EGFR inhibition in breast cancer. The gene discussed is EGFR; the disease is breast cancer.